{"uid":"cap_7yD1ha9NZgPbzkWnviHje","slug":"clinical-phase-analyzer-mcp-ae5c5a55","name":"Clinical Phase Analyzer MCP","description":"The premier global index of 1,069 monetized MCP nodes across 205 specialized subdomains. Gasless USDC runtime settlements via x402 V2 Spec on Base L2. Save 95% token context.","url":"https://api.m2mcent.com/clinical-phase-analyzer-mcp/api/process","method":"POST","headers":{},"bodySchema":{"type":"object","properties":{"payload":{"type":"string"}}},"responseSchema":{"type":"json","example":{"success":true}},"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.3","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.3/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.3","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.3","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_nrLtTu2luMBO3J0159cBU","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.3","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Analyzes clinical trial phase data or clinical text to extract, classify, and interpret pharmaceutical development phase information","exampleAgentPrompt":"Can you analyze this clinical trial description and tell me what development phase it's in: 'A randomized, double-blind study evaluating the safety and efficacy of compound XR-201 in 300 patients with moderate-to-severe rheumatoid arthritis, following successful Phase II dose-finding results'?","exampleUseCases":[{"title":"Drug pipeline phase classification","prompt":"I have this excerpt from a drug company's press release — can you analyze it and tell me which clinical phase this compound is in and what that means for its development timeline: 'Following promising results in healthy volunteers, BioPharma Inc. has initiated a multi-center study in 450 patients to assess therapeutic efficacy of BPI-447'?"},{"title":"Clinical trial portfolio screening","prompt":"Analyze this clinical study summary and classify its development phase for me: 'Open-label, dose-escalation study in 20 healthy adult volunteers to assess the safety, tolerability, and pharmacokinetics of a single ascending dose of NVX-300.'"},{"title":"Regulatory submission phase verification","prompt":"Can you parse this trial description and confirm what clinical phase it corresponds to so I can tag it correctly in our regulatory database: 'Confirmatory study in 1,200 subjects across 15 countries comparing NovaDrug to standard of care, designed to support NDA submission.'"}],"resultDescription":"Returns a structured analysis of the clinical phase identified in the input text, including the phase classification (e.g. Phase I, II, III, IV), key indicators used to determine the phase, and potentially contextual information about what that phase implies for drug development progress.","failureModes":["Empty or malformed 'data' string returns error or empty analysis","Ambiguous or non-clinical text may yield incorrect or low-confidence phase classification","Missing input field returns 400-level error","Non-English text may not be processed correctly","Highly abbreviated or jargon-heavy text without context may produce incorrect phase assignment","Payment failure via x402 protocol results in 402 response blocking the call"],"whenToPreferThis":"Choose this endpoint when you need to automatically classify or extract clinical trial phase information from unstructured text, such as press releases, protocol summaries, or regulatory filings. Prefer it over general-purpose NLP when your domain is specifically pharmaceutical clinical development phases and you need structured phase classification output. It is a cost-effective single-call solution at $0.30 USDC per analysis.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-15T07:03:52.941Z","isFirstParty":false}